Abstract
Resistant hypertension, defined as failure to achieve goal blood pressures in patients taking optimal or maximum tolerated doses of three or more antihypertensive drugs, is estimated to occur in about 25% of hypertensive patients on treatment. Poor adherence with treatment is considered to have an important role leading to apparent drug resistant hypertension. We have demonstrated that observed drug taking ('tablet feed'), followed by close monitoring of blood pressure in a clinic environment, together with ambulatory blood pressure monitoring, identifies a high proportion of patients (about two-thirds) of those presenting with resistant hypertension, whose persistently elevated blood pressure levels are due to poor adherence with drug treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
